This study investigates the patterns of gene mutation in patients who have different responses to chemotherapy. The research focuses on comparing those with a good response to treatment versus those with a poor response, as determined by their overall survival after being diagnosed with metastatic disease.
Participants in this study will undergo genetic testing to identify specific mutations. These tests help researchers understand how genetic differences may affect chemotherapy outcomes. Genetic testing involves analyzing DNA to look for changes or mutations that might influence the disease.
- Who can participate: Open to patients with metastatic disease who have undergone chemotherapy and are categorized as good or poor responders.
- Study details: Participants will provide samples for genetic testing to analyze gene mutations related to chemotherapy response.
